ArticleFrontiers in pharmacology2026
Pharmacokinetics, distribution, metabolism, excretion and safety characterization of ZJCK-6-72: novel DYRK1A inhibitor with optimized brain exposure for Alzheimer's disease therapy.
Zhenshu Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.